Skip to Main Content
Legislation Search

H.R. 7916: CODIS Access Modernization Act

The CODIS Access Modernization Act aims to improve the efficiency and speed of DNA evidence processing in the United States by allowing certain private forensic DNA testing laboratories to directly upload qualifying DNA profiles to the National DNA Index System (NDIS). Currently, only publicly operated forensic labs have this capability, which often leads to delays due to mandatory reviews when private labs conduct DNA testing for law enforcement agencies.

Key Provisions

  • Direct Uploads to NDIS: Eligible privately owned and operated forensic DNA testing laboratories will be authorized to upload qualifying DNA profiles directly to the NDIS, thereby streamlining the process and reducing the backlog.
  • Regulatory Framework: The Department of Justice and the Federal Bureau of Investigation will establish regulations that outline the criteria for laboratory eligibility, procedures for uploading DNA profiles, and security measures to ensure compliance with federal laws.
  • Limitations on Access: The bill specifies that private laboratories will not have the ability to search or retrieve information from the NDIS, limiting their access strictly to submitting DNA profiles.
  • Definition of Eligible Laboratories: Eligible laboratories must meet certain accreditation standards, including being accredited for at least five years under ISO/IEC 17025, undergoing regular audits, and ensuring compliance with federal security and privacy regulations.

Rationale Behind the Bill

Congress has identified several reasons for introducing this legislation:

  • To address the growing demand for forensic DNA testing amid increasing case volumes and backlogs in public laboratories, which impede timely justice.
  • To leverage the capabilities of accredited private laboratories that already perform DNA testing for various governmental and law enforcement sectors.
  • To enhance public safety by enabling faster identification of violent offenders and thereby preventing further crimes.
  • To reduce the burden on public laboratories, which can enhance their operational efficiency and allow them to focus on other crucial aspects of forensic science.

Expected Outcomes

By allowing private labs to upload DNA profiles directly to the NDIS, the bill is expected to achieve:

  • Faster case resolutions and increased closure rates for criminal investigations.
  • Enhanced DNA matches leading to arrests, potentially boosting public safety.
  • Increased efficiency by alleviating the workload on public labs, allowing them to manage their resources better.
  • A framework that employs the expertise of the private sector to address public safety issues, consistent with established federal practices.

Compliance and Oversight

The bill mandates that the Attorney General, in coordination with the FBI, will ensure that the necessary conforming amendments to current regulations and policies are made to meet the objectives of this legislation. This process will include updates to the NDIS Operational Procedures Manual and other relevant documents.

Effective Date

The act, upon its enactment, will take effect immediately. However, regulations governing the execution of the bill will need to be established within six months of that date.

Relevant Companies

  • ANVS – This company operates in the biotechnology sector and could potentially provide specialized DNA testing services.
  • ILMN – Illumina is a leading company in the field of genomics and could be impacted by this legislation as it may increase demand for private DNA testing services.
  • EXAS – Exact Sciences could also see an impact due to its involvement in genetic testing, which may align with the needs addressed by this legislation.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

1 sponsor

Actions

2 actions

Date Action
Mar. 12, 2026 Introduced in House
Mar. 12, 2026 Referred to the House Committee on the Judiciary.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Kevin Hern R / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION - COMMON STOCK
Sale $1,001 - $15,000
Apr 03, 2026 Mar 24, 2026 -
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
Mar 09, 2026 Feb 10, 2026 +8.91%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN _ILLUMINA, INC CMN
Sale $1,001 - $15,000
Feb 06, 2026 Jan 29, 2026 -13.24%
Congress pfp
Lisa C. McClain R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $1,001 - $15,000
Nov 21, 2025 Oct 31, 2025 +3.61%
Congress pfp
Lisa C. McClain R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $1,001 - $15,000
Nov 21, 2025 Oct 30, 2025 +29.78%
Congress pfp
Lisa C. McClain R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
Nov 21, 2025 Oct 30, 2025 +29.78%
Congress pfp
Lisa C. McClain R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
Aug 13, 2025 Jun 09, 2025 +37.89%
Congress pfp
Thomas H. Kean, Jr. R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
May 15, 2025 Apr 01, 2025 +42.88%
Congress pfp
Thomas H. Kean, Jr. R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Purchase $1,001 - $15,000
Apr 18, 2025 Apr 01, 2025 +42.88%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN ILLUMINA, INC CMN
Sale $1,001 - $15,000
Mar 06, 2025 Feb 25, 2025 +19.37%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $15,001 - $50,000
Sep 24, 2024 Sep 03, 2024 -26.20%
Congress pfp
Michael C. Burgess R / House
ILMN logo
ILMN ILLUMINA, INC. - COMMON STOCK
Sale $15,001 - $50,000
Oct 01, 2024 Aug 30, 2024 -24.50%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN ILLUMINA, INC CMN
Sale $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 -3.20%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN ILLUMINA, INC CMN
Purchase $1,001 - $15,000
Jun 05, 2024 May 29, 2024 -4.12%
Congress pfp
Ro Khanna D / House
ILMN logo
ILMN ILLUMINA, INC CMN
Sale $1,001 - $15,000
Jun 05, 2024 May 28, 2024 -7.21%
Congress pfp
Josh Gottheimer D / House
EXAS logo
EXAS EXACT SCIENCES CORPORATION - COMMON STOCK
Sale $1,001 - $15,000
Jun 08, 2024 May 10, 2024 +71.16%